Get Started
Multiple Sclerosis Curricula
Step 1

                              Virtual      Multiple
                 Grand Rounds      Sclerosis
  1. Course List
faculty image
James D. Bowen, MD
  • Medical Director Multiple Sclerosis Center
  • Swedish Neuroscience Institute
  • Seattle, Washington
  • Recent advances in understanding the pathophysiology of multiple sclerosis (MS) have made possible the development of exciting new treatment options. This nine-part virtual grand rounds series explores a number of important issues, illustrated by patient examples encountered in daily practice. Covered topics include the process of neural damage and the possibility that available and emerging agents may have a role in neuronal preservation; the latest data on current and emerging oral small molecules and monoclonal antibodies; the rationale for early diagnosis and intervention, criteria for evaluating response, and approaches to managing suboptimal response; optimizing the use of available agents in more aggressive regimens and possible drug combinations; managing walking impairment and neurogenic bladder dysfunction; balancing disease-modifying therapy and symptomatic therapy; managing breakthrough disease; and new and emerging therapies: is it time to change the status quo?
  • Assess the importance of early treatment intervention on disease progression and disability to ensure improved patient outcomes.
  • Assess and differentiate current and emerging small molecule MS therapies and how to integrate them into treatment regimens that optimize patient outcomes by slowing/stabilizing disease progression.
  • Utilize methodologies (eg, MRI)/tools to tailor treatment and personalize MS therapy to improve overall patient outcomes.
  • Integrate new strategies for optimizing immunosuppressive and immunomodulatory treatments, including induction therapy with an immunosuppressant followed by maintenance therapy with an immunomodulatory therapy, to control disease progression while minimizing side effects.
  • Utilize interventions that manage patient symptoms (walking impairment/spasticity, neurogenic bladder dysfunction) associated with MS in order to improve overall patient QOL.
  • Target Audience

    This series of activities is designed for neurologists and primary care physicians (including family practice, internists, and general practitioners), as well as nurses and pharmacists, who manage and treat patients with multiple sclerosis.


    Activity Goal

    The goal of this CME/CE activity is to examine current and emerging strategies for diagnosing, treating, and managing patients with multiple sclerosis.